Iomeprol

Iomeprol
Clinical data
Trade names	Imeron
AHFS/Drugs.com	International Drug Names
ATC code	V08AB10 (WHO) ;
Identifiers
	IUPAC name 1-N,3-N-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-methylacetamido)-2,4,6-triiodobenzene-1,3-dicarboxamide;
CAS Number	78649-41-9;
PubChem CID	3731;
ChemSpider	3600;
UNII	17E17JBP8L;
ChEBI	CHEBI:31710 ;
CompTox Dashboard (EPA)	DTXSID1049061 ;
Chemical and physical data
Formula	C17H22I3N3O8
Molar mass	777.089 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Ic1c(c(I)c(c(I)c1N(C(=O)CO)C)C(=O)NCC(O)CO)C(=O)NCC(O)CO;

Iomeprol is an iodinated molecule used as a contrast medium.

It is sold under the trade name Imeron, with the published formulations: Pharmaplan iodine content 250 mg, 300 mg, 350 mg and 400 mg/ml.[1]

It is classified as a water-soluble, nephrotrophic, low osmolar X-ray contrast medium.[1] The low osmolar non-ionic agents are better tolerated and less likely to cause side-effects than the high osmolar ionic agents.[1]

References

South African medicines formulary. Rossiter, Dawn., University of Cape Town. Division of Clinical Pharmacology., South African Medical Association (1998- ). Health and Medical Publishing Group. (11th ed.). Rondebosch, South Africa: Health and Medical Pub. Group of the South African Medical Association. 2014. ISBN 9781875098309. OCLC 869772940.CS1 maint: others (link)

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[:0-1] South African medicines formulary. Rossiter, Dawn., University of Cape Town. Division of Clinical Pharmacology., South African Medical Association (1998- ). Health and Medical Publishing Group. (11th ed.). Rondebosch, South Africa: Health and Medical Pub. Group of the South African Medical Association. 2014. ISBN 9781875098309. OCLC 869772940.CS1 maint: others (link)